The Lind Partners

Red Cat Holdings is a military technology company focused on integrating robotic hardware and software to deliver critical situational awareness and actionable intelligence for military operations. The company aims to enhance the effectiveness and safety of warfighters and battlefield commanders both domestically and globally. Red Cat offers a diverse range of solutions, including Teal Drones, which develops the Golden Eagle, a small unmanned system designed for high-resolution imaging during nighttime operations. Additionally, Red Cat collaborates with Skypersonic, which provides unmanned aircraft capable of operating in challenging environments, such as interior spaces. Furthermore, Red Cat is working on a fully-integrated drone supply chain that incorporates secure blockchain-based distributed storage, analytics, and software-as-a-service solutions, facilitating broader adoption within the drone industry.

Fortune Minerals Limited is a Canadian mining and development company that specializes in the exploration and development of specialty metals, base metals, and precious metals, primarily in the Northwest Territories. Founded in 1988 and headquartered in London, Ontario, the company holds a 100% interest in the NICO gold-cobalt-bismuth-copper project, which spans approximately 4,140 hectares. Additionally, it owns the Sue-Dianne deposit and the Salkeld Lake area, covering 451 and 116 hectares respectively. Fortune Minerals is currently focused on advancing the vertically integrated NICO project, which includes a proposed mine and mill that will produce a bulk concentrate. This concentrate is intended for shipment to a planned refinery in Saskatchewan, where the company aims to manufacture cobalt chemicals for rechargeable batteries, bismuth metals, and gold.

IRIDEX Corporation, established in 1989, specializes in developing, manufacturing, and marketing laser-based medical systems for ophthalmology. Its product portfolio includes therapeutic lasers like Cyclo G6 for glaucoma treatment, IQ series for retinal diseases, and OcuLight range for various eye conditions; delivery devices such as TxCell scanning laser delivery system and slit lamp adapter; and consumable instrumentation like MicroPulse P3 Probe and EndoProbe family of products. IRIDEX serves ophthalmologists and healthcare facilities worldwide through a direct sales force in the U.S. and international distributors, offering comprehensive technical support to ensure customer success.

Fortune Minerals Limited is a Canadian mining and development company that specializes in the exploration and development of specialty metals, base metals, and precious metals, primarily in the Northwest Territories. Founded in 1988 and headquartered in London, Ontario, the company holds a 100% interest in the NICO gold-cobalt-bismuth-copper project, which spans approximately 4,140 hectares. Additionally, it owns the Sue-Dianne deposit and the Salkeld Lake area, covering 451 and 116 hectares respectively. Fortune Minerals is currently focused on advancing the vertically integrated NICO project, which includes a proposed mine and mill that will produce a bulk concentrate. This concentrate is intended for shipment to a planned refinery in Saskatchewan, where the company aims to manufacture cobalt chemicals for rechargeable batteries, bismuth metals, and gold.

Know Labs, Inc. is a Seattle-based company that develops and markets innovative diagnostic technologies utilizing electromagnetic energy for substance identification and analysis. Its proprietary platforms, Bio-RFID and ChromaID, enable the non-invasive detection and authentication of various organic and inorganic materials. The company is advancing its Bio-RFID technology to create wearable devices, such as the UBAND glucose monitor, which aims to provide real-time blood glucose level measurements without the need for fingersticks or microneedles. Know Labs has established a research agreement with Mayo Clinic to further validate its Bio-RFID platform. Founded in 1998 and formerly known as Visualant, Incorporated, Know Labs continues to focus on enhancing healthcare solutions for individuals managing diabetes and related conditions.

Ainos is a medical technology company that provides low-dose interferon drug solutions, AI-powered medical devices and preventive medicine.

PARTS iD, Inc. is a technology-driven, digital commerce company focused on creating custom infrastructure and unique user experiences within niche markets.

GSE Systems, Inc. specializes in performance improvement solutions for the energy and process industries, focusing on enhancing human performance through training, visualization, and simulation applications. The company offers engineering expertise aimed at improving plant design, commissioning, and operations. GSE operates through two primary segments: engineering and workforce solutions, providing services such as interactive computer-based tutorials and simulation software tailored for the refining, chemical, and petrochemical sectors. With over 340 employees and more than four decades of experience, GSE Systems has completed over 1,100 installations and serves hundreds of clients across more than 50 countries. The company is headquartered in Sykesville, Maryland, and has additional offices in various locations including Georgia, North Carolina, Alabama, India, Sweden, the UK, Bahrain, and China.

HUB Security is a cybersecurity company founded in 2017 and based in Tel Aviv-Yafo, Israel. The company specializes in hardware security modules tailored for cloud, finance, and blockchain applications, addressing various security challenges such as signing flows, secure remote access, and regulatory compliance. With roots in elite Israeli Defense Forces intelligence units, HUB Security offers advanced encrypted computing solutions designed to thwart intrusions at the hardware level and prevent data theft. Its product portfolio includes secure key management and digital asset solutions for enterprises. Operating in over 30 countries, HUB Security provides a range of cybersecurity appliances and professional services, focusing on data security, system reliability, and risk management to protect sensitive commercial and government information.

PaxMedica Inc. is a clinical-stage biopharmaceutical company dedicated to developing anti-purinergic therapies for neurodevelopmental disorders. The company's primary focus is on innovative treatments for conditions like autism spectrum disorder, Fragile X syndrome, and Human African Trypanosomiasis. Its lead product candidate, PAX-101, is an intravenous formulation of suramin currently undergoing a Phase III clinical trial for Human African Trypanosomiasis and a Phase IIB trial for autism spectrum disorder, while also being in preclinical development for Fragile X syndrome. Additionally, PaxMedica is advancing PAX-102, an intranasal formulation of suramin in preclinical stages for various neurodevelopmental indications. Founded in 2018 and originally named Purinix Pharmaceuticals, the company is headquartered in Tarrytown, New York.

Else Nutrition offers plant-based nutrition products for the infant, toddler, children, and adult markets. It develops a plant-based non-soy alternative to dairy-based baby formula.

Bragg Gaming Group is a technology provider for the iGaming industry, offering a range of proprietary and exclusive casino gaming content. It develops high-performing, data-driven titles through its in-house studios, including Wild Streak Gaming, Spin Games, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. Bragg's content portfolio is supplemented by titles from selected studio partners, distributed via its Bragg Hub platform. The company also provides a player account management (PAM) platform and data analytics tools to enhance player engagement. Bragg primarily operates in the Netherlands and Curacao.

Seelos Therapeutics is a clinical-stage biopharmaceutical company based in New York, founded in 2016. It specializes in developing novel therapeutics to address unmet medical needs, particularly focusing on central nervous system (CNS) disorders and other rare conditions. The company's lead programs include SLS-002, an intranasal racemic ketamine for treating acute suicidal ideation and behavior in patients with major depressive disorder and post-traumatic stress disorder; SLS-005, a protein stabilizer for Sanfilippo syndrome; and SLS-006, a partial dopamine agonist for Parkinson's disease. Additionally, Seelos Therapeutics has several preclinical programs targeting various conditions such as Parkinson's disease, chronic inflammation in asthma, narcolepsy, and post-operative pain management.

Appili Therapeutics Inc. is a biopharmaceutical company based in Halifax, Canada, focused on acquiring, developing, and commercializing innovative medicines to address unmet needs in infectious diseases. Founded in 2015, the company has a diverse anti-infective portfolio that includes several clinical candidates. These include Favipiravir for pandemic influenza and COVID-19, ATI-2307, an antifungal agent for cryptococcal meningitis and invasive candidiasis, and ATI-1501, a taste-masked oral formulation of the antibiotic metronidazole. Additionally, Appili is developing ATI-1503, which targets gram-negative bacteria, and ATI-1701, a live-attenuated vaccine for Francisella tularensis. Through its work, Appili Therapeutics aims to provide effective solutions for patients suffering from serious infections.

Magnis Energy Technologies Limited, established in 2005 and headquartered in Sydney, Australia, is primarily engaged in the exploration and development of mineral properties, with a focus on natural flake graphite used in lithium-ion batteries for energy storage. The company holds a 100% interest in the Nachu graphite project located in southeast Tanzania, which produces high-quality graphite concentrate sought after for its purity and crystal structure in battery anode production. Magnis also engages in research and production of lithium-ion batteries through its partnership with C4V, utilizing patented materials and technology licensed exclusively from the Nachu project's graphite.

Bioasis Technologies Inc. is a biopharmaceutical company focused on the research and development of innovative products aimed at diagnosing and treating neurological diseases and disorders. The company has developed the xB3 platform, a proprietary technology designed to facilitate the delivery of therapeutics across the blood-brain barrier, which is critical for addressing central nervous system disorders. Bioasis is actively working on treatments for brain cancers and neurodegenerative diseases, with specific in-house programs targeting brain metastases, glioblastoma, and other neurodegenerative conditions. Founded in 2007 and headquartered in Guilford, Connecticut, Bioasis is dedicated to addressing unmet medical needs in the field of neurology through its advanced therapeutic delivery systems.

ComSovereign is a provider of telecommunications solutions that focuses on enabling 5G connectivity and data transmission systems. The company has developed a diverse portfolio of advanced communication technologies, including signal modulation, antennas, software, hardware, and firmware. By integrating various niche technologies, ComSovereign aims to enhance spectral efficiency and connectivity across the entire data transmission spectrum. Its offerings include wireless transport solutions, edge compute-capable 4G LTE and 5G network systems, as well as tethered drones and aerostats. ComSovereign primarily generates its revenue from North America and serves a wide range of clients, including network operators, mobile device carriers, governmental units, and other enterprises globally.

Boxlight is an education technology company focused on providing innovative solutions to enhance learning experiences in classrooms. The company develops, sells, and services a comprehensive suite of interactive technologies, including flat panel displays, LED video walls, classroom audio systems, and media players. Additionally, Boxlight offers digital signage and a range of peripherals to support educational environments. Beyond the education sector, the company also caters to corporate and government clients. Boxlight is committed to improving student engagement and outcomes by delivering integrated solutions that encompass software, professional development, and ongoing support services. Furthermore, the company distributes STEM products, such as 3D printing and robotics solutions, to enrich educational offerings.

Noxopharm Limited is an Australian drug development company specializing in the research and development of innovative therapies aimed at enhancing the effectiveness of radiotherapy and chemotherapy for late-stage cancers. The company's lead product, Veyonda, is a first-in-class, dual-acting drug designed to improve the safety and efficacy of traditional cancer treatments, allowing for reduced dosages of these therapies. In addition to Veyonda, Noxopharm is developing several other drug candidates, including NYX-330, a PCSK9 inhibitor for lowering LDL cholesterol; NYX-104, a neuroprotectant for brain injury; and NYX-205, an anti-inflammatory drug targeting nerve tissue inflammation. The company is also pursuing anti-autoimmune treatments and has collaborations with notable research institutions, including the Hudson Institute of Medical Research and The Australian National University, to advance its therapeutic offerings. Established in 2015, Noxopharm is headquartered in Gordon, Australia.

Avalon Advanced Materials is a mineral exploration and development company that specializes in critical metals and minerals essential for emerging technologies. The company focuses on the extraction and processing of rare metals, including lithium, tantalum, niobium, cesium, indium, gallium, germanium, rare earth elements, yttrium, and zirconium. Its key projects include East Kemptville, Lilypad, Nechalacho, Separation Rapids, and Warren Township, all of which are aimed at tapping into the growing demand for these vital materials. Through its initiatives, Avalon Advanced Materials is positioned to contribute significantly to the supply of critical resources necessary for modern advancements.

Vamp is a global influencer marketing and content creation platform that connects brands such as Adobe, Estée Lauder, and Nestlé with its vetted community of creators to execute effective campaigns. As a trusted partner of major social media platforms like Facebook, TikTok, and YouTube, Vamp offers an omni-channel, self-serve solution for brands to reach their customers on social media. The platform's creators produce premium, mobile-first content that meets marketing goals, whether published in social feeds, transformed into ad units, or placed into targeted paid media campaigns. Founded in Australia in 2015, Vamp has a global presence with teams based in Sydney, Hong Kong, Singapore, Dubai, London, Jakarta, and Tokyo, having completed campaigns in 65 countries.

Identitii Limited is an Australian RegTech company that develops and licenses enterprise software for banks and money service businesses both locally and internationally. Founded in 2014 and based in Woolloomooloo, the company’s primary offering is Overlay+, a digital platform designed to mitigate regulatory risks without necessitating changes to existing technology systems. Overlay+ facilitates ISO 20022 migration, foreign exchange transactions, and AUSTRAC reporting, thereby providing clients with enhanced visibility and control over their regulatory compliance data. By employing tokenization, Identitii aids financial institutions in streamlining payment processing, enabling them to manage payment timelines and details more effectively. While the company primarily generates revenue in Australia, it also has operational footprints in Asia and the United States.